Literature DB >> 1674679

Autoradiographic localization of beta-adrenergic receptors in human large coronary arteries.

F Amenta1, L Coppola, P Gallo, F Ferrante, A Forlani, A Monopoli, P Napoleone.   

Abstract

The distribution of beta-adrenergic receptors in sections of the human right and left coronary arteries and of the anterior intraventricular branch was studied by the use of combined in vitro radioreceptor binding and autoradiographic techniques. [125I]Cyanopindolol was used as a ligand for beta-adrenergic receptors. Binding of the radioligand to sections of the three coronary arteries under study was saturable, stereoselective, reversible, and displaceable by antagonists and agonists with the rank order of potency expected for beta-adrenergic receptors. Analysis of binding isotherms indicated maximum binding capacities of 41.5 fmol/mg protein for the right coronary artery, 35.4 fmol/mg protein for the left coronary artery, and 25.7 fmol/mg protein for the anterior interventricular branch. Dissociation constants were approximately 35 pM in the arteries examined. The relative amounts of beta 1- and beta 2-receptor subtypes were as follows: 72% beta 1-receptors and 28% beta 2-receptors in the right coronary artery; 65% beta 1-receptors and 35% beta 2-receptors in the left coronary artery; 40% beta 1-receptors and 60% beta 2-receptors in the anterior interventricular branch. The results of autoradiographic analysis revealed a predominance of beta 1-receptors in the medial layer. beta 2-Receptors were localized primarily in the adventitia, in the adventitia-media border, and in the intimal layer. These results should lead to a better understanding of the mechanisms involved in the control of coronary circulation in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674679     DOI: 10.1161/01.res.68.6.1591

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Authors:  Ana M Briones; Craig J Daly; Francesc Jimenez-Altayo; Sonia Martinez-Revelles; Jose M Gonzalez; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Muscarinic cholinergic receptors in the human right coronary artery: a receptor binding and autoradiographic study.

Authors:  F Amenta; M De Michele; P Strocchi; F Ferrante; P Gallo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

Review 3.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Pharmacological characterization and anatomical localization of prejunctional beta-adrenoceptors in the rat kidney.

Authors:  P P Lakhlani; F Amenta; P Napoleone; L Felici; D C Eikenburg
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Nitric oxide formation contributes to beta-adrenergic dilation of epicardial coronary arteries in response to intravenous administration of dobutamine in dogs.

Authors:  Haoyi Yang; Youbin Deng; Xiaojun Bi; Qing Chang; Jiao Bai; Min Pan; Huijuan Xiang; Hongyun Liu; Xiulan Li; Yani Liu; Chunlei Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  β-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase.

Authors:  Jacqueline K Limberg; Rebecca E Johansson; Garrett L Peltonen; John W Harrell; J Mikhail Kellawan; Marlowe W Eldridge; Joshua J Sebranek; William G Schrage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-08       Impact factor: 4.733

7.  Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart.

Authors:  F Amenta; P Gallo; A Rossodivita; A Ricci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.